A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Children's Oncology Group
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Seattle Children's Hospital
St. Jude Children's Research Hospital
Hadassah Medical Organization
British Columbia Cancer Agency